{"id":309443,"date":"2010-02-11T23:12:09","date_gmt":"2010-02-12T04:12:09","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=63120"},"modified":"2010-02-11T23:12:09","modified_gmt":"2010-02-12T04:12:09","slug":"verdezyne-raises-9m","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/309443","title":{"rendered":"Verdezyne Raises $9M"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/industrial-biotechnology\/\">Industrial Biotechnology<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/funding\/\">funding<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Venture-Capital\/\">Venture Capital<\/a><\/div>\n<p>\t\t<strong>Bruce V. Bigelow wrote:<\/strong><\/p>\n<p>Carlsbad, CA-based Verdezyne, an industrial biotechnology company developing methods for using yeast to make industrial chemicals, has raised $9 million in an ongoing $15.2 million venture round, according to spokeswoman Risa Goldman Burgess. She said today the funding is being used to validate technology, which Verdezyne recently disclosed, for making adipic acid, a key feedstock chemical used to make nylon. Verdezyne&#8217;s existing investors include Monitor Ventures, OVP Venture Partners, the Tech Coast Angels, and the Life Sciences Angels.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/02\/11\/verdezyne-raises-9m\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Verdezyne%20Raises%20$9M%20http:\/\/xconomy.com\/?p=63120\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/san-diego\/2010\/02\/11\/verdezyne-raises-9m\/&#038;t=Verdezyne%20Raises%20$9M\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/san-diego\/2010\/02\/11\/verdezyne-raises-9m\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Verdezyne+Raises+%249M&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fsan-diego%2F2010%2F02%2F11%2Fverdezyne-raises-9m%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=b6ffaa550b01aa9fd6d2fe7b3ecfb64c&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=b6ffaa550b01aa9fd6d2fe7b3ecfb64c&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/a.rfihub.com\/eus.gif?eui=2218\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ah_hciCVhdIRm7OnFhc38o35fuo\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ah_hciCVhdIRm7OnFhc38o35fuo\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ah_hciCVhdIRm7OnFhc38o35fuo\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ah_hciCVhdIRm7OnFhc38o35fuo\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/qllCrYgRPsE\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Industrial Biotechnology, funding, Venture Capital Bruce V. Bigelow wrote: Carlsbad, CA-based Verdezyne, an industrial biotechnology company developing methods for using yeast to make industrial chemicals, has raised $9 million in an ongoing $15.2 million venture round, according to spokeswoman Risa Goldman Burgess. She said today the funding is being used to validate technology, which Verdezyne [&hellip;]<\/p>\n","protected":false},"author":5423,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-309443","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/309443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/5423"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=309443"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/309443\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=309443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=309443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=309443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}